Oculoplastic Surgery Market To Reach $14.02 Billion By 2030

Oculoplastic Surgery Market Growth & Trends

The global oculoplastic surgery market size is expected to reach USD 14.02 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to register a 6.05% CAGR over the forecast period. The market is primarily driven by the rising geriatric population, increasing number of oculoplastic surgical procedures, and technological advancements in the medical aesthetics industry. Furthermore, increasing patient awareness and rising disposable income are also fueling the growth. Factors such as the rising disposable income, standard of living, social media influence, and awareness among people are anticipated to bode well for the growth.

According to the results from a survey conducted by the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS), social media has massive impact on aesthetics, especially in the way consumers perceive and project themselves. The survey results highlighted that 55% of facial plastic surgeons consulted patients who wanted to look better in selfies in 2017, showing a 13% increase from the previous year.

With a wide range of oculoplastic surgery procedures available in the market, more people are willing to undergo such treatment due their affordability and feasibility. Furthermore, rising medical tourism and better reimbursement policies are also boosting the market growth. The medical tourism market is anticipated to witness significant growth over the forecast period, which is expected to bode well for the overall market for oculoplastic surgery.

 Request a free sample copy or view report summary: Oculoplastic Surgery Market Report

Oculoplastic Surgery Market Report Highlights

• North America accounted for the largest market share in 2023, owing to the presence of favorable reimbursement policies, presence of key players, and supportive government initiatives

• By procedure, eyelid segment accounted for the largest market share and is expected to maintain its dominance during the forecast period.

• Browlift and forehead lift segment is expected to register the fastest growth during the forecast period owing to high adoption of this surgery

• Some of the key companies in the oculoplastic surgery market are Bausch + Lomb, Carl Zeiss Meditec AG, Stryker, and Integra LifeSciences Corporation. These players are focusing on new product launches to introduce advanced services

Oculoplastic Surgery Market Segmentation

Grand View Research has segmented the global oculoplastic surgery market based on product, procedure, end-use, and region:

Oculoplastic Surgery Product Outlook (Revenue, USD Million, 2018 - 2030)

• Instruments

  • Forceps

  • Knife Handles and Blades

  • Scissors

  • Needle Holders

  • Clamps

  • Hooks and Retractors

  • Others

• Implants & Grafts

• Equipment

Oculoplastic Surgery Procedure Outlook (Revenue, USD Million, 2018 - 2030)

• Eyelid Surgery

• Facelift

• Brow Lift/ Forehead Lift

• Pediatric Oculoplastic Surgery

• Orbital surgery

Oculoplastic Surgery End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals and Clinics

• Ambulatory Surgical Centers

Oculoplastic Surgery Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Norway

  • Sweden

  • Denmark

• Asia Pacific

  • China

  • Japan

  • India

  • Thailand

  • South Korea

  • Australia

• Latin America

  • Mexico

  • Brazil

  • Argentina

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Oculoplastic Surgery Market

• Surgical Holdings

• Matrix Surgical USA

• Integra LifeSciences Corporation

• Stryker

• FCI

• Bolton Surgical Ltd

• RUMEX International Co.

• BVI Medical

• Carl Zeiss Meditec AG

• Bausch + Lomb